Clinical Trials Logo

Clinical Trial Summary

This is a prospective, multi-center, randomized, dose escalation study to document the effects of adventitial delivery of temsirolimus (Torisel) after revascularization of lesions below the knee in symptomatic patients with critical limb ischemia (CLI).


Clinical Trial Description

This is a prospective, multi-center, randomized, dose escalation study to document the effects of adventitial delivery of temsirolimus (Torisel) after revascularization of lesions below the knee in symptomatic patients with critical limb ischemia (CLI). Up to 60 patients (20 low-dose, 20 high-dose and 20 control) at up to 15 sites in the United States. This study will assess the safety and effectiveness of Bullfrog Micro-Infusion Device adventitial deposition of temsirolimus in reducing intimal hyperplasia, inflammatory markers and composite safety endpoints in patients with clinical evidence of chronic critical limb ischemia after revascularization of one or more angiographically significant lesion(s) in below-knee popliteal or tibial vessels. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02908035
Study type Interventional
Source Mercator MedSystems, Inc.
Contact
Status Active, not recruiting
Phase Phase 2
Start date March 3, 2017
Completion date September 2021

See also
  Status Clinical Trial Phase
Recruiting NCT00768495 - Hyperspectral Imaging Pre and Post Endovascular Intervention N/A
Completed NCT03294902 - Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System
Active, not recruiting NCT02479620 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization Phase 2
Recruiting NCT02479555 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization Phase 2
Not yet recruiting NCT03847597 - Histological and Imaging Assessment of the Structural Characteristics of the Femoro-popliteal Arterial Segment
Recruiting NCT06416644 - The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) N/A